Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD Oil for PTSD
NCT04197102Phase 2Suspended
- Sponsor
- University of Texas at Austin
- Start
- Jan 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in post-traumatic stress disorder (PTSD), sponsored by University of Texas at Austin. Started Jan 2020; status: suspended.
02
Drugs
cannabidiol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04197102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04197102.